Author

Alexey Terentiev

Observed names: A S Terent'ev, A. S. Terentiev, A. Terentiev, A.S. Terentiev, А. С. Терентьев, А.С. Терентьев, Терентьев А.С., Терентьев Алексей Семенович
ORCID: 0000-0003-1184-0374
Observed ORCID: 0000-0003-1184-0374
OpenAlex ID: A5040066754
2014 · Liubov Beduleva, Igor Menshikov, et al. · International Journal of Rheumatic Diseases · 30
2016 · Alexandr Sidorov, Liubov Beduleva, et al. · International Journal of Biological Macromolecules · 19
2022 · Liubov Beduleva, Alexandr Sidorov, et al. · Immunologic Research · 9
2021 · Liubov Beduleva, Tatyana Khramova, et al. · International Immunopharmacology · 7
2023 · L. Beduleva, A. Sidorov, et al. · Journal of Endocrinological Investigation · 6
2023 · Tatyana Khramova, Liubov Beduleva, et al. · Immunological Investigations · 6
2023 · Liubov Beduleva, Alexandr Sidorov, et al. · International Journal of Biological Macromolecules · 6
2020 · Kseniya Fomina, Liubov Beduleva, et al. · Immunity Inflammation and Disease · 4
2020 · Liubov Beduleva, Elena Stolyarova, et al. · Journal of Immunoassay and Immunochemistry · 3
2025 · Liubov Beduleva, Kseniya Fomina, et al. · Scientific Reports · 2
2024 · Igor Cherepanov, Alexandr Sidorov, et al. · The Protein Journal · 2
2023 · Liubov Beduleva, Kseniya Fomina, et al. · Immunological Investigations · 2
2022 · Igor Cherepanov, Alexandr Sidorov, et al. · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · 2
2022 · I.V. Menshikov, A.K.A. Zerjawi, et al. · Immunologiya · 1
2017 · Elena Stolyarova, Liubov Beduleva, et al. · Endocrine Metabolic & Immune Disorders - Drug Targets · 1
2026 · D. I. Menshikova, A. S. Terentiev, et al. · Russian Journal of Immunology
2025 · Pavel V. Ivanov, A. Yu. Sidorov, et al. · Russian Journal of Immunology
2024 · K. V. Fomina, T. V. Khramova, et al. · Russian Journal of Immunology
2014 · Столярова Елена Юрьевна, Иванов Павел Владимирович, et al. · Вестник Удмуртского университета. Серия «Биология. Науки о Земле»
Works count: 27
Citation count: 105
H-index: 6
I10-index: 2
Year
Topic
Type